← Back to Clinical Trials
Recruiting NCT06277778

NCT06277778 Effect of Combined Music and Taekwondo Training for Children with Autism Spectrum Disorder

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06277778
Status Recruiting
Phase —
Sponsor The Hong Kong Polytechnic University
Condition Autism Spectrum Disorder
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2024-06-30
Primary Completion 2026-06-30

Eligibility & Interventions

Sex All sexes
Min Age 7 Years
Max Age 9 Years
Study Type INTERVENTIONAL
Interventions
Taekwondo training with music therapyTaekwondo training alone

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 70 participants in total. It began in 2024-06-30 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this randomized controlled trial is to evaluate the effect of combined music and taekwondo training on the mental and physical condition of children with autism spectrum disorder. Participants will be asked to do combined music and taekwondo training or taekwondo training alone to evaluate if the combined training is better than the taekwondo training alone on mental and physical performance for children with autism spectrum disorder.

Eligibility Criteria

Inclusion Criteria: * Chinese children aged 7 to 9 years who have been clinically diagnosed as ASD by developmental paediatricians or clinical psychologists based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria for ASD. Exclusion Criteria: * children who have experience in Taekwondo training; * children who have received music therapy within the previous 12 months; * those who have severe sensory disorders (blindness or deafness); * those who have underlying congenital abnormalities or other diseases that limit their ability to engage in physical activities.

Contact & Investigator

Central Contact

Clare CW YU, PhD

✉ clare-chung-wah.yu@polyu.edu.hk

📞 +85234003251

Principal Investigator

Clare CW YU, PhD

PRINCIPAL INVESTIGATOR

Assistant Professor

Frequently Asked Questions

Who can join the NCT06277778 clinical trial?

This trial is open to participants of all sexes, aged 7 Years or older, up to 9 Years, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06277778 currently recruiting?

Yes, NCT06277778 is actively recruiting participants. Contact the research team at clare-chung-wah.yu@polyu.edu.hk for enrollment information.

Where is the NCT06277778 trial being conducted?

This trial is being conducted at Hong Kong, Hong Kong.

Who is sponsoring the NCT06277778 clinical trial?

NCT06277778 is sponsored by The Hong Kong Polytechnic University. The principal investigator is Clare CW YU, PhD at Assistant Professor. The trial plans to enroll 70 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology